Use of SAPT vs DAPT beyond 12 months in patients with AMI: Clinical impact on ischemic risk
This study demonstrated SAPT vs DAPT was associated with significantly lower MACCE within 12 to 36 months in patients who had suffered from AMI, had undergone a successful PCI with second-generation DES, and had not experienced any adverse clinical events within the first 12 months